Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carelite is a topical skin-lightening and depigmenting cream developed by Surecare Pharma. It is formulated as a non-steroidal preparation designed to reduce hyperpigmentation, dark spots, and uneven skin tone while providing UV protection. The cream contains a combination of active ingredients, including kojic acid dipalmitate (a stable skin-brightening agent that inhibits melanin production), sodium ascorbyl phosphate (a stable form of vitamin C that provides antioxidant protection and brightens the skin), bioflavonoid-rich pine bark extract (which protects against oxidative stress and supports collagen production), and aloe vera extract (which hydrates and soothes the skin). Carelite is used to promote a clearer, more radiant complexion and protect the skin from sun-induced damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Carelite.